C
Changchun BCHT Biotechnology Co
SSE:688276
Changchun BCHT Biotechnology Co
SSE:688276
Price:
17.25
CNY
-5.74%
Market Closed
Market Cap:
¥7.1B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
C
|
Changchun BCHT Biotechnology Co
SSE:688276
|
CN |
|
Nordea Bank Abp
OTC:NBNKF
|
FI |
|
F
|
First Philippine Holdings Corp
XPHS:FPH
|
PH |
|
Erie Indemnity Co
NASDAQ:ERIE
|
US |
|
Ten Pao Group Holdings Ltd
HKEX:1979
|
HK |
|
Gogo Inc
NASDAQ:GOGO
|
US |
|
Golden Mile Resources Ltd
ASX:G88
|
AU |
|
C
|
CNPC Capital Co Ltd
SZSE:000617
|
CN |
|
Vita Life Sciences Ltd
ASX:VLS
|
AU |
|
E I D-Parry (India) Ltd
NSE:EIDPARRY
|
IN |
|
China Yangtze Power Co Ltd
SSE:600900
|
CN |
|
E
|
Eureka Forbes Ltd
BSE:543482
|
IN |
|
F
|
Fullsun International Holdings Group Co Ltd
HKEX:627
|
HK |
|
FinVolution Group
NYSE:FINV
|
CN |
|
M
|
Mitsubishi Materials Corp
TSE:5711
|
JP |
|
A
|
Australian Unity Office Fund
ASX:AOF
|
AU |
|
Pineapple Energy Inc
NASDAQ:PEGY
|
US |
|
Acciona SA
MAD:ANA
|
ES |
|
Canadian Natural Resources Ltd
TSX:CNQ
|
CA |
|
CloudMD Software & Services Inc
XTSX:DOC
|
CA |
Relative Value
The Relative Value of one Changchun BCHT Biotechnology Co stock under the Base Case scenario is hidden CNY. Compared to the current market price of 17.25 CNY, Changchun BCHT Biotechnology Co is hidden .
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
Changchun BCHT Biotechnology Co Relative Value
HIDDEN
Multiples Across Competitors
Competitors Multiples
Changchun BCHT Biotechnology Co Competitors
Changchun BCHT Biotechnology Co Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| CN |
C
|
Changchun BCHT Biotechnology Co
SSE:688276
|
7.1B CNY | 10.5 | -41.9 | -32.7 | -32.7 | |
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD | 33 690 872.8 | -160 127.7 | -194 446.1 | -192 227.3 | |
| US |
|
Abbvie Inc
NYSE:ABBV
|
362.3B USD | 5.9 | 86.5 | 14.4 | 20 | |
| US |
|
Amgen Inc
NASDAQ:AMGN
|
188.5B USD | 5.1 | 24.4 | 14.2 | 14.2 | |
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
170.4B USD | 5.8 | 20 | 12.5 | 15.5 | |
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
114.6B USD | 9.5 | 29 | 21.8 | 22.8 | |
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR | 2 091 | -533.6 | -581 | -565.5 | |
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
77.9B USD | 5.4 | 17.3 | 12.7 | 14.5 | |
| AU |
|
CSL Ltd
ASX:CSL
|
67.4B AUD | 3.1 | 34.2 | 11.3 | 14.2 | |
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR | 20.1 | -61.8 | -66.6 | -60.1 | |
| US |
|
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
|
40.6B USD | 10.9 | 129.6 | 72.5 | 80.5 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
